Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Non-Current Deferred Tax Liability (2018 - 2020)

Summit Therapeutics (SMMT) has disclosed Non-Current Deferred Tax Liability for 2 consecutive years, with $2.1 million as the latest value for Q3 2020.

  • For the quarter ending Q3 2020, Non-Current Deferred Tax Liability changed N/A year-over-year to $2.1 million, compared with a TTM value of $2.1 million through Sep 2020, changed N/A, and an annual FY2019 reading of $2.1 million, changed N/A over the prior year.
  • Non-Current Deferred Tax Liability was $2.1 million for Q3 2020 at Summit Therapeutics, up from $2.1 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $2.1 million in Q3 2020 and bottomed at $2.1 million in Q4 2019.